FundedIQ
Health Care

Spry

SPRY Therapeutics, Inc. is the inventor of SPRY EMR, an integrated practice management solution that enables rehab therapy professionals to succeed in practice and in business—from the front desk to clinical operations to the back office. Built on a future-focused architecture, the SPRY platform adapts to the changing clinical and business needs of physical therapists, occupational therapists, and speech language pathologists. Since 2021, SPRY has earned a reputation for flexible workflow customizations, short migration times, and high-velocity claims processing—in one single platform, at one simple price.

thesprypt.com New Jersey, Trinidad and Tobago 51-100 employees
Total raised
$15.0M
Rounds
1
Latest
Series B
Oct 2024

SPRY Therapeutics, Inc. is the inventor of SPRY EMR, an integrated practice management solution that enables rehab therapy professionals to succeed in practice and in business—from the front desk to clinical operations to the back office. Built on a future-focused architecture, the SPRY platform adapts to the changing clinical and business needs of physical therapists, occupational therapists, and speech language pathologists. Since 2021, SPRY has earned a reputation for flexible workflow customizations, short migration times, and high-velocity claims processing—in one single platform, at one simple price.

Spry has raised $15.0M across 1 round. Its most recent round was a Series B of $15.0M in Oct 2024. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Oct 9, 2024
Series B
$15.0M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Spry is featured in

Similar companies

Early Intervention Systems

The Early Intervention Systems software has been developed to enhance the efficiency of caregivers and reduce negative outcomes for the elderly within memory-care communities. This innovative healthcare tool provides workers with cutting-edge software solutions.

Seed $120k
Spry

Nimble is a cloud-based working framework that permits development wellbeing experts to gather and examine patient information progressively.

Series A $6.9M
Health ID

Health ID is a health tech company.

Equity Crowdfunding $1.1M
Holobiome

Holobiome is a company that specializes in developing therapies for diseases affecting the enteric and central nervous systems. Using microbiome-based treatments, the company aims to address a range of mental health issues, as well as metabolism and immune responses. Founded in 2015, Holobiome is located in Cambridge, Massachusetts.

Seed $10.0M
Firsthand

Firsthand knowledge of severe mental illness, in our opinion, ought to be valued more. Our founding group of healthcare experts and serial entrepreneurs have purposefully devoted their professional lives to assisting marginalised individuals with serious mental illnesses in collaboration with local nonprofits. We are actively expanding our team with like-minded business creators.

Series Unknown $10.0M
CurieDx

CurieDx is the image-based diagnostics using a smartphone photograph, they assist patients in recovering more quickly.

Seed $200k
Estrigenix Therapeutics

Estrigenix Therapeutics, Inc. is a non-public pharmaceutical company with a goal of creating ground-breaking medications to enhance the mental well-being of women experiencing menopause. Inaugurated in 2018, Estrigenix Therapeutics aims to enhance women's health, starting with addressing the physical and psychological impacts of menopause.

Seed $2.0M
Karoo Health

Karoo Health is a leader in tech-enabled value-based cardiovascular care solutions and aims to bring innovative, end-to-end, cardiovascular solutions to patients via partnerships with health plans and self-insured employers. As a patient-first organization, Karoo Health’s mission is to help patients lead their best lives by providing a new paradigm of better cardiology care, at lower cost, than the current system and preventing the progression of cardiovascular disease.

Series A $16.2M
Neko Health

Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the maintenance of good health through preventive measures and early detection. Their innovative medical scanning technology concept enables the convenient and cost-effective collection of comprehensive health data, without the need for invasive procedures, making it accessible to the general public.

Series C $700M
410 Medical

A medical device firm called 410 Medical is committed to creating cutting-edge technologies that help doctors provide better treatment for seriously ill patients. The recently approved LifeFlow® PLUS device from 410 is intended to increase the speed and effectiveness of volume resuscitation, enhancing the treatment of patients with life-threatening illnesses such sepsis, bleeding, and cardiac arrest.

Series Unknown $12.0M
Fibroheal

Fibroheal Woundcare Pvt Ltd focuses on leveraging silk proteins to create biomedical applications for effective wound care. The company develops advanced medical devices aimed at addressing various types of wounds, including acute and chronic cases.

Seed $1.5M
Leo Cancer Care

Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills hope. Founded in Australia, Leo Cancer Care is grounded in international research on the advantages of upright patient positioning. Through a shift from machine rotation to patient rotation, Leo Cancer Care is positioned to revolutionize radiation therapy.

Series D $65.0M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.